Hoppa till innehållet

OMXSPI+0,11%

S&P 500+0,44%

FTSE 100-0,08%

DAX+0,14%

NIKKEI+1,26%
Redeye: Stille Q3 2023: Beat on sales and EBIT – positive outlook and attractive valuation

Redeye recognizes a solid Q3 report from Stille, which unveiled nuggets such as 18% y/y sales growth and EBIT margin of 16%, both slightly surpassing our estimates. The current valuation indicates EV/EBIT of 11.8 for 2023, marking a notable discount compared to historical multiples.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Stille Q3 2023: Beat on sales and EBIT – positive outlook and attractive valuation

Source:MFN
Tillbaka

Det verkar som att du använder en annonsblockerare

Om du är prenumerant behöver du logga in för att fortsätta. Vill du bli prenumerant kan du läsa Di Digitalt för 197 kr inkl. moms de första 3 månaderna.

spara
1180kr
Prenumerera